Pursued the IBEAR MBA Program (STEM) which focuses on Strategic Leadership Development for Senior Executives

• Implemented the separation efforts for divestiture of Merck Consumer Health division to P&G (project partnered with PwC); leading to successful transition along with mapping of revised vision and future growth levers• Led JV partnership with Pfizer for the launch of Avelumab which included high level of cross-functional collaboration and resulted in establishing 10% market share in $40M Renal Cancer market in Y1 of launch• Steered turnaround project for tier-2/3 cities of the underperforming ‘North Zone’ of cardiology business unit resulting in 24% share of growth in the $110M market with an increase in HCP outreach by 21% in FY 2020• Facilitated primary market research project with IPSOS for launch of fertility brand ‘Pergoveris’ in India, which mapped patient journey and market clusters of IVF patients resulting in $5m sales in Y1 of launch and 20% share• Delivered monthly reporting of industry analysis, therapy & portfolio analysis and KPIs using various secondary sources like IQVIA, IPSOS, Nielsen which were instrumental in competitive tracking and strategic decision making

• Led the ‘5-year vision’ consulting project (partnered with McKinsey) which helped in mapping strategic imperatives for driving long-term growth• Established and tracked monthly KPIs critical for monitoring performance and decision making by leadership team• Managed overall corporate governance for the CEO which involved a high level of cross-functional networking

• Spearheaded four primary market research projects across therapies to provide key inputs for Annual Brand plans• Conducted market sizing exercises regularly to identify and update covered markets for each therapy, brand and region• Implemented ‘Sales Force synergy’ project for which direction was provided for optimal resource allocation• Established and tracked monthly KPIs critical for monitoring performance and decision making by leadership team

• Managed five key accounts of IQVIA in India (including Merck) worth $18M with a 12% increase in annual revenue• Provided analytical support to the health consulting team which facilitated efficient project delivery of four projects• Presented 7 customized ‘Point-of-View’ client presentations which provided detailed insights and recommendations• Clients Managed: Merck, Abbott Group, Sigma-Tau, Religare, Indoco (Contributed 20% towards annual revenue)

• Generated 18 new business opportunities worth $3.3m for Biocon's B2B out-licensing startup division ‘FIDOZE’• Received ‘MD's award’ in 2010 for attaining highest sales of $6.8m in the Western India region in FY 2010 • Managed 11 customers valued $11m with 48% CAGR in 2 years from 2009 to 2011 (Top 3: Abbott, Ferring, Cipla)